Cite

HARVARD Citation

    Dela Cruz Chuh, J. et al. (2021). Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor response. MAbs. 13 (1), p. . [Online]. 
  
Back to record